Details of the Drug Therapeutic Target (DTT)

General Information of Drug Therapeutic Target (DTT) (ID: TTPZI04)

DTT Name	Voltage-dependent anion channel (VDAC)
Gene Name	VDAC
DTT Type	Clinical trial target	[1]
BioChemical Class	Eukaryotic mitochondrial porin
UniProt ID	NOUNIPROTAC
TTD ID	T60348
Function	Forms a channel through the mitochondrial outer membrane that allows diffusion of small hydrophilic molecules.

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This DTT

1 Clinical Trial Drug(s) Targeting This DTT

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
VDA-1102	DMAJ85O	Actinic keratosis	EK90.0	Phase 2	[2]
------------------------------------------------------------------------------------

References

1	Involvement of voltage-dependent anion channel (VDAC) in dengue infection. Sci Rep. 2016 Oct 25;6:35753.
2	Clinical pipeline report, company report or official report of Vidac Pharma.